Author

G. Palapattu

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Assay:metabolomics· 1 Approach:statistical model· 1

Frequent Co-Authors

A. Sreekumar· 1 shared A. Zaslavsky· 1 shared B. W. Simons· 1 shared C. Charles· 1 shared D. R. Rowley· 1 shared D. W. B. Piyarathna· 1 shared G. T. lee· 1 shared I. Y. Kim· 1 shared

Activity by Year

2019-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Sreekumar

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Role of Adenosine Deaminase in Prostate Cancer Progression

C. Charles, S. M. Lloyd, D. W. B. Piyarathna, J. Gohlke, U. Rasaily, V. Putluri, B. W. Simons, A. Zaslavsky, S. Nallandhighal, N. Palanisamy, N. Navone, J. A. Jones, M. M. Ittmann, N. Putluri, D. R. Rowley, , A. Sreekumar

This study identifies adenosine deaminase (ADA) as a driver of prostate cancer progression and metastasis through metabolomics and in vitro/in vivo experiments.

bioRxiv · Aug 9, 2023 · PreprintCancer Biology

TCF4 induces enzalutamide resistance via neuroendocrine differentiation in prostate cancer

G. T. lee, W. T. Kim, Y. S. Kwon, G. Palapattu, W.-J. Kim, I. Y. Kim

This study identifies TCF4 as a driver of enzalutamide resistance in prostate cancer through neuroendocrine differentiation.

bioRxiv · Feb 25, 2019Cancer Biology